Optical in vivo and ex vivo imaging of glioma cells migration via the cerebral vessels: Prospective clinical application of the beta2-adrenoreceptors blockade for glioma treatment

Optical in vivo and ex vivo imaging of glioma cells migration via the cerebral vessels: Prospective clinical application of the beta2-adrenoreceptors blockade for glioma treatment

Malignant gliomas are highly invasive tumors that use the cerebral vessels for invasion due to high vascular fragility of the blood–brain barrier (BBB). On one hand, glioma is characterized by the BBB disruption, on the other hand, drug brain delivery via the BBB is a big challenge in glioma therapy...

Full description

Bibliographic Details
Main Authors:	Olga Pavlova, Alexander Shirokov, Alexander Fomin, Nikita Navolokin, Andrey Terskov, Alexander Khorovodov, Anton Namykin, Alexey Pavlov, Valery Tuchin, Oxana Semyachkina-Glushkovskaya
Format:	Article
Language:	English
Published:	World Scientific Publishing 2018-07-01
Series:	Journal of Innovative Optical Health Sciences
Subjects:	Glioma macrophages blood–brain barrier beta-2-adrenoreceptors beta-arrestin-1
Online Access:	http://www.worldscientific.com/doi/pdf/10.1142/S1793545818500256

Similar Items

Trial watch: beta-blockers in cancer therapy
by: Killian Carnet Le Provost, et al.
Published: (2023-12-01)

Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report
by: Taiki Kato, et al.
Published: (2021-02-01)

β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance
by: Maura Calvani, et al.
Published: (2020-06-01)

Polymorphism Trp64Arg of beta 3 adrenoreceptor gene: allelic frequencies and influence on insulin resistance in a multicenter study of Castilla-León Polimorfismo TRP64ARG del gen receptor beta 3: frecuencia alélica e influencia en la resistencia a la insulina en un estudio multicéntrico de Castilla y León
by: D. A. de Luis, et al.
Published: (2010-04-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

ADRENORECEPTOR SENSITIVITY AND MAGNESIUM THERAPY IN PATIENTS WITH CARDIAC ARRHYTHMIAS AND CONNECTIVE TISSUE DYSPLASIA
by: G. I. Nechaeva, et al.
Published: (2012-08-01)

Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule
by: Serena Milano, et al.
Published: (2021-08-01)

Adrenoreceptors and nitric oxide in the cardiovascular system
by: Valeria eConti, et al.
Published: (2013-11-01)

RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
by: Paola Bonsi, et al.
Published: (2019-01-01)

Evaluation methods of α and β2-adrenoreactivity of human erythrocytes to change their osmotic resistance under the effect of adrenaline and adrenoblockers
by: F. O. Voloh
Published: (2017-01-01)

Evaluation methods of α and β2-adrenoreactivity of human erythrocytes to change their osmotic resistance under the effect of adrenaline and adrenoblockers
by: F. O. Voloh
Published: (2017-01-01)

Influence of α<sub>2</sub>-Adrenoreceptor Antagonists on Electroencephalogram Characteristics after Dexmedetomidine Administration in Rabbits
by: A. Yu. Grishina, et al.
Published: (2023-03-01)

Impairment of Hypoxia-Induced CA IX by Beta-Blocker Propranolol—Impact on Progression and Metastatic Potential of Colorectal Cancer Cells
by: Monika Barathova, et al.
Published: (2020-11-01)

THE GENE OF ALPHA2A-ADRENORECEPTOR AND ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2014-11-01)

β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation
by: Amada Pasha, et al.
Published: (2021-03-01)

ß-Adrenoreceptors in Human Cancers
by: Zoltan Kraboth, et al.
Published: (2023-02-01)

Association between β2-Adrenoreceptor Medications and Risk of Parkinson’s Disease: A Meta-Analysis
by: Chu-Ling Chen, et al.
Published: (2021-09-01)

BETA-ADRENORECEPTORS GENETIC POLYMORPHISM CONNECTION WITH BETA-BLOKER THERAPY EFFICACY IN PATIENTS WITH CARDIOVASCULAR DISORDERS
by: A.A. Svistunov, et al.
Published: (2009-03-01)

The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway
by: Paul Bigliardi, et al.
Published: (2024-01-01)

β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding
by: Elsa Wilma Böhm, et al.
Published: (2023-02-01)

Functional Polymorphism in the <i>ADRB3</i> Gene, Encoding the Beta-3 Adrenergic Receptor, and Response to Intra-Detrusor Injection of Botulinum Toxin-A in Women with Overactive Bladder
by: Sylwester Michał Ciećwież, et al.
Published: (2022-12-01)

Clinical Outcomes Depending on Sympathetic Innervation in Pancreatic Cancer
by: Elena-Anca Târtea, et al.
Published: (2023-06-01)

Polymorphism Glu389Arg of β1-adrenoreceptor gene and cardiovascular complications of hyperthyroidism
Published: (2010-06-01)

The Contribution of the Common Single-nucleotide Polymorphisms of β1-Adrenoreceptor Gene to Cardiovascular Alteration in Patients with Thyrotoxicosis
Published: (2014-06-01)

Role of Noradrenaline and Adrenoreceptors in Regulating Prostaglandin E2 Synthesis Cascade in Inflamed Endometrium of Pigs
by: Barbara Jana, et al.
Published: (2023-03-01)

Share on vk Share on google_plusone_share Share on twitter Share on email More Sharing Services Stimulation of α1-adrenoreceptors inhibits myocardial contractility in rats
by: T.L. Zefirov, et al.
Published: (2018-12-01)

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
by: Genesio Di Muro, et al.
Published: (2023-06-01)

Behavioral and Molecular Responses to Exogenous Cannabinoids During Pentylenetetrazol-Induced Convulsions in Male and Female Rats
by: Antonella Zirotti Rosenberg, et al.
Published: (2022-08-01)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
by: Arryn T. Blaine, et al.
Published: (2022-08-01)

β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
by: Serena Milano, et al.
Published: (2023-01-01)

Different Effects of Phototherapy for Rat Glioma during Sleep and Wakefulness
by: Alexander Shirokov, et al.
Published: (2024-01-01)

Role of cardiac α1-adrenoreceptors for the torsadogenic action of IKr blocker nifekalant in the anesthetized atrioventricular block rabbit
by: Satoshi Kawakami, et al.
Published: (2022-10-01)

Endothelial β‐arrestins regulate mechanotransduction by the type II bone morphogenetic protein receptor in primary cilia
by: Saejeong Park, et al.
Published: (2022-10-01)

Nedd4 E3 ligase and beta-arrestins regulate ubiquitination, trafficking, and stability of the mGlu7 receptor
by: Sanghyeon Lee, et al.
Published: (2019-08-01)

Photomodulation of lymphatic delivery of liposomes to the brain bypassing the blood-brain barrier: new perspectives for glioma therapy
by: Semyachkina-Glushkovskaya Oxana, et al.
Published: (2021-07-01)

Repurposing <i>α</i>-Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria
by: Ahmad J. Almalki, et al.
Published: (2022-01-01)

Ciliary signaling proteins are mislocalized in the brains of Bardet-Biedl syndrome 1-null mice
by: Toneisha Stubbs, et al.
Published: (2023-01-01)

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
by: Kendall L. Mores, et al.
Published: (2019-04-01)

Editorial: Hormone Action and Signal Transduction in Endocrine Physiology and Disease
by: Tamas Balla, et al.
Published: (2020-08-01)

Asthma: Effect of Genotype on Response to Therapy in the Emergency Department
by: Henderson, Sean, et al.
Published: (2007-08-01)